A detailed history of Blair William & CO transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, Blair William & CO holds 24,300 shares of SENS stock, worth $7,776. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,300
Previous 24,300 -0.0%
Holding current value
$7,776
Previous $9,000 11.11%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$0.37 - $0.52 $370 - $520
-1,000 Reduced 3.95%
24,300 $9,000
Q3 2023

Nov 09, 2023

BUY
$0.5 - $1.05 $1,250 - $2,625
2,500 Added 10.96%
25,300 $15,000
Q1 2023

May 12, 2023

SELL
$0.68 - $1.25 $85 - $156
-125 Reduced 0.55%
22,800 $16,000
Q4 2022

Feb 10, 2023

BUY
$0.96 - $1.34 $120 - $167
125 Added 0.55%
22,925 $23,000
Q4 2021

Feb 14, 2022

BUY
$2.58 - $3.91 $58,824 - $89,148
22,800 New
22,800 $61,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $149M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Blair William & CO Portfolio

Follow Blair William & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.